Substance
LINACLOTIDE
Global reference: every product and company linked to this substance.
- cas: 851199-59-2
- ncit: C81001
- pubchem_cid: 16158208
- rxnorm: 1307404
- unii: N0TXR0XR5X
ASP-0456 · ASP0456 · linaclotide [INN] · LINACLOTIDE [JAN] · LINACLOTIDE [USAN] · Linaclotide [WHO-DD] · LINZESS · MD-1100 · MD-7246 (DELAYED RELEASE FORMULATION)
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ABBVIE INC. COMMON STOCK | LINZESS | Q2 2026 | $295.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- LINACLOTIDE · VIATRIS INC. COMMON STOCK
- LINZESS · ABBVIE INC. COMMON STOCK